images (7)
FAQ's
Answer : The global subcutaneous drug delivery devices market size was estimated at US$ 23.4 billion in 2020 and is expected to hit US$ 56.9 billion by 2030 with a registered CAGR of 9.3% from 2021 to 2030.
Answer : The global subcutaneous drug delivery devices market size was estimated at US$ 23.4 billion in 2020 and is expected to hit US$ 56.9 billion by 2030 with a registered CAGR of 9.3% from 2021 to 2030.
Answer : The rising adoption of the various subcutaneous drug delivery devices by the consumers to control and manage their chronic health conditions is fueling the market growth.
Answer : The major players operating in the subcutaneous drug delivery devices market are Insulet Corporation, Enable Injections, Amgen, BD, Consort Medical Plc, Ypsomed AG, Eli Lilly, Novo Nordisk, Sanofi, Merck, AstraZeneca.
Answer : North America dominated the global subcutaneous drug delivery devices market, garnering a market share of more than 43% in 2020.
Get a Sample of this Report
images (7)
